NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.960
+0.060 (3.16%)
At close: Aug 14, 2026, 4:00 PM EDT
1.970
+0.010 (0.49%)
After-hours: Aug 14, 2026, 7:55 PM EDT
NovaBridge Biosciences Employees
NovaBridge Biosciences had 30 employees as of December 31, 2025. The number of employees decreased by 2 or -6.25% compared to the previous year.
Employees
30
Change (1Y)
-2
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$2,944,667
Market Cap
226.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 30 | -2 | -6.25% |
| Dec 31, 2024 | 32 | -188 | -85.45% |
| Dec 31, 2023 | 220 | -158 | -41.80% |
| Dec 31, 2021 | 378 | 150 | 65.79% |
| Dec 31, 2020 | 228 | 43 | 23.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Tonix Pharmaceuticals Holding | 142 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Immunic | 95 |
| Keros Therapeutics | 92 |
| Compugen | 75 |
| AN2 Therapeutics | 21 |
NBP News
- 2 days ago - NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026 - GlobeNewsWire
- 22 days ago - NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026 - GlobeNewsWire
- 6 weeks ago - NovaBridge CEO Xi-Yong Fu to step down, Srishti Gupta to succeed - TheFly
- 6 weeks ago - NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer - GlobeNewsWire
- 2 months ago - NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer - GlobeNewsWire
- 2 months ago - NovaBridge Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - NovaBridge Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts